Vera Damuzzo

9PUBLICATIONS
15CO-AUTHORS
Molecular targetsHealth counsellingCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 15, 2026
Long-term outcomes of ALK inhibitors in metastatic ALK-positive non-small cell lung cancer: an updated indirect comparison using reconstructed patient-level data.

|Jun 26, 2025
Enhancing oncology care: A prospective observational study on counseling practices of hospital pharmacists.

S A M Urru, S Masucci, P Baldo

|Jan 24, 2025
Treatment Options for Advanced Non-Small Cell Lung Cancer After Failure of Previous Immune Checkpoint Inhibitors and Chemotherapy: Meta-Analysis of Five Randomized Controlled Trials.

Andrea Messori, Andrea Ossato, Lorenzo Gasperoni

|Aug 03, 2022
Immune checkpoint inhibitors as first line in advanced melanoma: Evaluating progression-free survival based on reconstructed individual patient data.

Andrea Ossato, Vera Damuzzo, Paolo Baldo

|Feb 16, 2018
Optimization of resources by drug management: A multicentred web-administered study on the use of ipilimumab in Italy.

V Damuzzo, A Russi, M Chiumente

|Apr 12, 2017
Ipilimumab in real-world clinical practice: efficacy and safety data from a multicenter observational study.

Alberto Russi, Vera Damuzzo, Marco Chiumente

Pageof 2

Frequent Collaborators

2 joint publications

Marco Chiumente

2 joint publications

Alessandro Inno

2 joint publications

Daniele Mengato

2 joint publications

Luna Del Bono